Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$23,500,000
Company Info
- Founders
- Robert Farra
- Company Description
- A biotech company developing a pre-programmed, passive drug delivery system through pulsating dosing. Omnipulse Biosciences offers single injection quantities suitable for clinical trials and commercial distribution to low-income countries
- Market
- Healthcare & Wellness
- Coinvestors
- BOLD Capital Partners,Safar Partners,Trousdale Ventures
Links